Extended Data Fig. 1: Clinical Study Design and Summary of Data Collection. | Nature Medicine

Extended Data Fig. 1: Clinical Study Design and Summary of Data Collection.

From: Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infection

Extended Data Fig. 1

A, Clinical study design. Participants were treated with VE303 or placebo after being randomized 1:1:1 into treatment groups. CDI recurrence was evaluated at Week 8, with additional efficacy and safety follow-up through Week 24. B, Metagenomic, metabolomic, and immune datasets examined in the study. C, Sample collection summary (N = total samples, R = samples from recurrent individuals, NR = samples from non-recurrent individuals) for VE303-dosed groups up to Day 14.

Source data

Back to article page